Meier-Gorlin syndrome mutations disrupt an Orc1 CDK inhibitory domain and cause centrosome reduplication

Area of Science:

• Cell Biology
• Molecular Biology
• Genetics

Background:

• Centrosome duplication, like DNA replication, is tightly regulated to occur once per cell cycle, ensuring genetic stability.
• The Orc1 subunit of the human origin recognition complex plays a role in regulating both DNA replication and centrosome copy number.

Purpose of the Study:

• To investigate the mechanisms by which Orc1 controls centrosome duplication and its relationship with DNA replication.
• To determine the role of specific Orc1 domains and mutations, particularly those found in Meier-Gorlin syndrome, in regulating centrosome copy number.

Main Methods:

• Characterization of Orc1 domains, including a PACT centrosome-targeting domain and a kinase inhibitory domain.
• Analysis of Orc1's interaction with Cyclin E-CDK2 and Cyclin A-CDK2, and its inhibition of their kinase activities.
• Investigation of Meier-Gorlin syndrome-associated Orc1 mutations and their impact on centrosome duplication.

Main Results:

• Orc1 possesses distinct domains for centrosome targeting and differential inhibition of Cyclin E-CDK2 and Cyclin A-CDK2 kinase activities.
• A cyclin-binding motif (Cy motif) in Orc1 is crucial for Cyclin A binding and inhibition, but not for Cyclin E inhibition.
• Meier-Gorlin syndrome mutations in Orc1 disrupt Cyclin E-CDK2 inhibition and lead to centrosome reduplication.

Conclusions:

• Orc1 contains separate functional domains that independently regulate centrosome copy number and DNA replication.
• Orc1's dual role in DNA replication and centrosome duplication is critical for normal cell division.
• Alterations in Orc1 function due to Meier-Gorlin syndrome mutations may contribute to microcephaly and dwarfism by affecting centrosome duplication alongside DNA replication defects.